{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T01:54:47Z","timestamp":1773194087131,"version":"3.50.1"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T00:00:00Z","timestamp":1538697600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012399","name":"Biomedical Advanced Research and Development Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"DOI":"10.3389\/fcimb.2018.00356","type":"journal-article","created":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T04:50:29Z","timestamp":1538715029000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Rabbitpox in New Zealand White Rabbits: A Therapeutic Model for Evaluation of Poxvirus Medical Countermeasures Under the FDA Animal Rule"],"prefix":"10.3389","volume":"8","author":[{"given":"Mark R.","family":"Perry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Warren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Merchlinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Houchens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James V.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,10,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"11084","DOI":"10.1128\/JVI.00423-07","article-title":"Rabbitpox virus and vaccinia virus infection of rabbits as a model for human smallpox","volume":"81","author":"Adams","year":"2007","journal-title":"J. Virol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1586\/14787210.2014.979157","article-title":"Discovery of forgotten variola specimens at the National Institutes of Health in the USA","volume":"12","author":"Arita","year":"2014","journal-title":"Expert. Rev. Anti. Infect. Ther"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/path.1700850102","article-title":"Rabbit pox: an experimental study of the pathways of infection in rabbits","volume":"85","author":"Bedson","year":"1963","journal-title":"J. Pathol. Bacteriol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1177\/0300985810378649","article-title":"Animal models of orthopoxvirus infection","volume":"47","author":"Chapman","year":"2010","journal-title":"Vet. Pathol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"7659","DOI":"10.1016\/j.vaccine.2011.07.140","article-title":"The NYCBH vaccinia virus deleted for the innate immune invasion gene, E3L, protects rabbits against lethal challenge by rabbitpox virus","volume":"29","author":"Denzler","year":"2011","journal-title":"Vaccine"},{"key":"B6","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly-attenuated MVA smallpox vaccine and protection against monkeypox","volume":"428","author":"Earl","year":"2004","journal-title":"Nature"},{"key":"B7","unstructured":"FennerF.\n            HendersonD. A.\n            AritaI.\n            JezekZ.\n            LadnyiI.D\n          GenevaWorld Health OrganizationSmallpox and Its Eradication1988"},{"key":"B8","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3390\/v8070203","article-title":"Ectromelia virus disease characterization in the BALB\/c mouse: a surrogate model for assessment of smallpox medical countermeasures","volume":"8","author":"Garver","year":"2016","journal-title":"Viruses"},{"key":"B9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1084\/jem.60.4.427","article-title":"Rabbit pox I. Clinical manifestations and course of disease","volume":"60","author":"Greene","year":"","journal-title":"J. Exp. Med"},{"key":"B10","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1084\/jem.60.4.441","article-title":"Rabbit pox II. Pathology of the epidemic disease","volume":"60","author":"Greene","year":"","journal-title":"J. Exp. Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3181\/00379727-30-6724","article-title":"A pandemic of rabbit-pox","volume":"30","author":"Greene","year":"1933","journal-title":"Proc. Soc. Exp. Biol. Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1084\/jem.61.6.807","article-title":"Rabbit pox III. Report of an epidemic with especial reference to epidemiological factors","volume":"61","author":"Greene","year":"1935","journal-title":"J. Exp. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1056\/NEJMoa1705688","article-title":"Oral Tecovirimat for the Treatment of Smallpox","volume":"379","author":"Grosenbach","year":"2018","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.antiviral.2017.04.002","article-title":"Efficacy of delayed brincidofovir treatment against a lethal rabbitpox virus challenge in New Zealand White rabbits","volume":"143","author":"Grossi","year":"2017","journal-title":"Antiviral Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"15196","DOI":"10.1073\/pnas.0405954101","article-title":"Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox","volume":"101","author":"Jahrling","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B16","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1128\/JCM.42.2.601-609.2004","article-title":"Smallpox and pan-orthopox virus detection by real-time 3'-minor groove binder TaqMan assays on the roche lightcycler and the cepheid smart cycler platforms","volume":"42","author":"Kulesh","year":"2004","journal-title":"J. Clin. Microbiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.antiviral.2008.03.005","article-title":"Evaluation of orally delivered ST-246 as postexposure prophylactic and antiviral therapeutic in an aerosolized rabbitpox rabbit model","volume":"79","author":"Nalca","year":"2008","journal-title":"Antiviral Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1099\/vir.0.026237-0","article-title":"Rabbitpox: a model of airborne transmission of smallpox","volume":"92","author":"Nalca","year":"2011","journal-title":"J. Gen. Virol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e0188453","DOI":"10.1371\/journal.pone.0188453","article-title":"Construction of an infectious horsepoxvirus virus vaccine from chemically synthesized DNA fragments","volume":"13","author":"Noyce","year":"2018","journal-title":"PLoS ONE"},{"key":"B20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/v3020063","article-title":"Efficacy of CMX001 as a prophylactic and presymptomatic antiviral agent in New Zealand white rabbits infected with rabbitpox virus, a model for orthopoxvirus infections in humans","volume":"3","author":"Rice","year":"","journal-title":"Viruses"},{"key":"B21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/v3010047","article-title":"Efficacy of CMX001 as a post exposure antiviral in New Zealand white rabbits infected with rabbitpox virus, a model for orthopoxvirus infections in humans","volume":"3","author":"Rice","year":"","journal-title":"Viruses"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.3390\/v2092096","article-title":"Use of the aerosol rabbitpox virus model for evaluation of anti-poxvirus agents","volume":"27","author":"Roy","year":"2010","journal-title":"Viruses"},{"key":"B23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.antiviral.2015.02.007","article-title":"The efficacy and pharmacokinetics of brincidofovir for the treatment of lethal rabbitpox virus infection: a model of smallpox disease","volume":"117","author":"Trost","year":"2015","journal-title":"Antiviral Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.antiviral.2011.11.013","article-title":"Evaluation of inhaled cidofovir as postexposure prophylactic in an aerosol rabbitpox model","volume":"93","author":"Verreault","year":"2012","journal-title":"Antiviral Res"},{"key":"B25","first-page":"453","article-title":"Experimental respiratory infection with poxviruses. Clinical virological and epidemiological studies","volume":"47","author":"Westwood","year":"1966","journal-title":"Br. J. Exp. Pathol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2018.00356\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T04:50:42Z","timestamp":1538715042000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2018.00356\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,5]]},"references-count":25,"alternative-id":["10.3389\/fcimb.2018.00356"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2018.00356","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,5]]},"article-number":"356"}}